Latest Period
n/a
Security Snapshot
Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") Institutional Ownership
CUSIP: 002942100
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
Shares (Excl. Options)
Price
$3.77
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share (the "Shares")
- Shares outstanding
- 21,303,054
- SEC-reported price per share
- $3.77
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- 002942100 - Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") is tracked under CUSIP 002942100.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 3 to 1 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $28,414,746 to $4,283.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
002942100
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 002942100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
002942100
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 5.6% | 1,192,971 | Kenneth Griffin | 14 Feb 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
n/a
Rows shown
1-2 of 2